Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
From outside firms

Analysis and Perspectives

Commentary and analysis from outside consulting and policy firms. Not part of Medicaid Monitor's independently scored news coverage. Each piece links back to the firm's original publication.

Milliman · Jun 8

Texas Medicaid MCO Financial Performance Shows Membership Declines and Margin Pressure Through Redetermination Period

Milliman's quarterly financial analysis of Texas Medicaid managed care plans through Q4 SFY 2025 documents how the end of continuous coverage protections affected MCO enrollment, net income, and medical loss ratios across STAR, STAR Kids, STAR+PLUS, CHIP, and dual-eligible programs. The report examines financial metrics including directed payment pass-through expenses, administrative costs, and experience rebate impacts as plans navigated large-scale eligibility redeterminations. State Medicaid directors and MCO finance teams can use these program-specific benchmarks to assess operational performance during the unwinding period and inform rate-setting discussions.

Read at milliman.com →
Milliman · May 5

Milliman Urges States to Leverage Medicaid Financing for Child Welfare Behavioral Health Services

This white paper argues that state child welfare agencies should strategically realign funding by expanding Medicaid coverage for behavioral health and clinical services while reserving Title IV-E federal funds for safety and permanency supports that Medicaid cannot cover. The authors contend that better coordination between Medicaid and child welfare financing can reduce fragmentation, decrease reliance on congregate care settings, and stabilize state budgets as federal Title IV-E reimbursement declines. For Medicaid managed care leaders, this presents both an opportunity and a challenge: MCOs may see expanded behavioral health service obligations for foster and at-risk children while state agencies seek stronger cross-system data sharing and care coordination.

milliman.com →
Milliman · Apr 8

D-SNP Growth Stalls as Plans Shift Dual Eligibles to C-SNPs to Avoid State Medicaid Contracts

Milliman's analysis of 2026 Medicare Advantage data reveals that D-SNP enrollment growth remains minimal outside of states transitioning Medicare-Medicaid Plans, while plans increasingly use C-SNPs to enroll dual eligibles and sidestep state Medicaid agency contracting requirements. The trend reflects MAO responses to tightening CMS integration requirements and state policies limiting D-SNP availability, with implications for how dual eligibles access coordinated Medicare-Medicaid benefits. The shift raises questions for state Medicaid agencies about care coordination oversight and whether dual eligibles in C-SNPs receive comparable integration as those in contracted D-SNPs.

milliman.com →
Milliman · Apr 2

Four Ways MCOs and States Can Use New Federal Provider Payment Data for Network Strategy and Oversight

Milliman examines how state Medicaid agencies and managed care plans can leverage HHS's newly released open-source dataset of provider-level Medicaid spending from 2018-2024, which includes service-level payments across both fee-for-service and managed care. The analysis identifies four strategic applications including contract negotiation support, fraud detection, network adequacy planning, and benchmarking—while noting data limitations and interpretation challenges MCOs should consider when using national aggregated claims data for operational decisions.

milliman.com →
Milliman · Mar 30

Milliman Maps Options for Plans to Keep Drug Costs Low for Dual Eligibles After VBID, FAI Sunset

Milliman examines how the discontinuation of the Medicare Advantage VBID demonstration and the Medicare-Medicaid Financial Alignment Initiative removes key tools that states and plans used to reduce Part D cost-sharing to $0 for low-income dual-eligible beneficiaries. The paper outlines four remaining strategies—alternative Part D benefit designs, Medicaid value-added services, state pharmacy assistance programs, and state-only funds—that Medicaid agencies and Dual-Eligible Special Needs Plans can use to preserve affordable drug access. This matters for Medicaid managed care because millions of dual eligibles enrolled in D-SNPs relied on these now-sunsetting programs, requiring states and plans to redesign benefit and funding approaches.

milliman.com →
Milliman · Mar 27

Global Budget Models Shift Insurance Risk to Providers, Require Strategic Alignment for Success

This piece outlines six implementation requirements for hospitals entering global budget arrangements, which shift traditional insurance risk from health plans to provider systems. While focused primarily on Medicare models like CMS's AHEAD program and state all-payer demonstrations, the shift affects how Medicaid managed care organizations structure provider contracts and share risk. MCO compliance and finance teams should understand these models as they increasingly appear in Medicaid alongside Medicare and commercial payers.

milliman.com →
Milliman · Mar 17

Milliman's 2026 MA Report Tracks D-SNP Benefit Value and Trends for Dual-Eligible Members

Milliman's white paper uses its MACVAT tool to assess how Medicare Advantage dual-eligible special needs plans (D-SNPs) are valuing and designing benefits for 2026 compared to 2025, measuring supplemental benefits, cost-sharing reductions, and premium buydowns beyond traditional Medicare. While focused on Medicare Advantage economics, the analysis is relevant to Medicaid managed care stakeholders because D-SNPs serve dually eligible beneficiaries and require close coordination with state Medicaid programs and managed care plans serving this population.

milliman.com →
Milliman · Mar 17

Why Cutting Medicaid Enrollment Won't Save States What They Expect in Managed Care Programs

Milliman explains why state savings from Medicaid enrollment reductions are often overstated in managed care environments. When lower-cost members disenroll—such as through work requirements—average capitation rates rise because the remaining enrolled population becomes sicker and more expensive, meaning states don't save the full per-member capitation amount. The firm provides an interactive modeling tool to help states understand the complex fiscal dynamics of eligibility changes, including federal match implications, MCO tax structures, and administrative costs.

milliman.com →
Milliman · Mar 9

Suspicious Catheter Billing Spikes Could Skew ACO Benchmarks, Milliman Warns

Milliman analysts flag a sharp, anomalous rise in Medicare FFS payments for a specific urinary catheter billing code in Q3 2025, echoing a pattern CMS previously addressed by excluding similar codes from ACO benchmark calculations in MSSP and REACH models. The piece argues CMS should again adjust future benchmark years to prevent ACOs from being unfairly penalized by suspect billing activity outside their control. While centered on Medicare ACO programs rather than Medicaid directly, the methodology and anomaly-detection approach are relevant to Medicaid managed care actuaries and compliance teams monitoring similar billing integrity risks.

milliman.com →
Milliman · Mar 9

New Federal ACO LEAD Model Opens Door for States and MCOs to Integrate Dual-Eligible Care

CMS's 10-year ACO LEAD demonstration will test Medicare-Medicaid integration in two states—one using managed care, one fee-for-service—with enhanced payment models designed to support complex, high-need dual-eligible populations. Milliman's analysis outlines participation scenarios and strategic considerations for state Medicaid agencies, managed care plans, ACOs, and providers as they evaluate partnership opportunities under the new model. The piece examines how different stakeholder approaches could shape member outcomes, financial performance, and care coordination for dually eligible beneficiaries.

milliman.com →
Milliman · Mar 5

Drug Pricing 101: Decoding WAC, ASP, AMP and Other Terms Across Payers

Milliman breaks down eight common pharmaceutical pricing benchmarks—including WAC, ASP, AMP, AWP, NADAC, and Maximum Fair Price—explaining how each is calculated and used across the drug supply chain. While several of these metrics (like AMP and NADAC) directly underpin Medicaid drug rebate and reimbursement calculations, the piece is a broad educational reference for life sciences companies rather than a focused Medicaid managed care analysis.

milliman.com →
Milliman · Mar 3

State Medicaid Agencies Face New Performance Management Demands Under 2024 CMS Quality Rating Rule

This white paper examines how state Medicaid agencies can strengthen their oversight of MCOs through improved performance management systems, particularly in light of the 2024 CMS final rule requiring quality rating systems by 2028. The analysis outlines common challenges states face in monitoring managed care programs and proposes strategies for using data and performance measures more effectively to drive improvements in access, quality, and equity. The piece is directly aimed at helping state Medicaid directors and MCO oversight teams adapt to heightened federal accountability requirements while building stronger partnerships with health plans.

milliman.com →
Milliman · Feb 9

How Risk Adjustment Systems Drive Medicaid Plan Revenue and Formulary Decisions

Life sciences companies seeking to understand Medicaid managed care purchasing behavior need to grasp how risk adjustment models translate member acuity into plan payments and profitability. The piece explains that Medicaid capitation rates are risk-adjusted based on enrollee health conditions and demographics, directly affecting plan revenue and financial performance. Because risk scores influence plan margins, they also shape formulary design and coverage decisions—meaning pharmaceutical manufacturers must account for how their products affect plan risk profiles and reimbursement.

milliman.com →
Milliman · Dec 10

Milliman Compares Capital Strategies of For-Profit vs. Nonprofit Health Insurers

Milliman's analysis finds for-profit health insurers typically operate with lower risk-based capital (RBC) ratios and higher leverage, relying on frequent capital contributions and dividends from parent companies, while nonprofit insurers hold significantly more capital and surplus due to limited access to outside capital. The piece is relevant to Medicaid MCO compliance and finance teams because many Medicaid managed care plans operate under one of these two ownership models, and understanding capital adequacy norms matters for solvency oversight and state regulatory review, though the analysis is not Medicaid-specific.

milliman.com →
Milliman · Dec 4

White Paper Outlines Best Practices for Medicaid MCO Risk Adjustment Operations

Milliman's second installment in a risk adjustment series argues that effective risk adjustment depends on coordinated organizational infrastructure—not just coding accuracy—spanning governance, staffing, provider engagement, data systems, and compliance functions. The paper provides operational benchmarks and leading practices applicable across Medicare Advantage, Medicaid, and ACA plans, with direct implications for how Medicaid managed care organizations structure teams, oversee vendors, and integrate risk adjustment into care management and revenue integrity workflows.

milliman.com →
Milliman · Nov 12

White Paper Examines Risk Adjustment Operations Across Medicaid, Medicare Advantage, and ACA Plans

Milliman's white paper provides guidance on optimizing risk adjustment operations across public programs including Medicaid managed care, focusing on how accurate documentation and coding ensure plans receive appropriate capitated payments that reflect member health status. The piece addresses how health plans can align risk adjustment processes with financial performance, emphasizing that risk scores directly influence revenue in capitated payment models. While it covers multiple programs, the operational and financial implications are directly relevant to Medicaid MCO compliance and finance teams managing risk-based payments.

milliman.com →
Milliman · Oct 22

Medicare Advantage Plans Pivot Toward Dual-Eligible Members for 2026

Milliman's analysis of CMS's 2026 MA landscape file finds that insurers are shrinking non-special-needs MA-PD offerings while sharply expanding dual-eligible special needs plans (D-SNPs, up 10%) and chronic special needs plans (C-SNPs, up 44%), continuing a multi-year strategic shift toward higher-acuity, dual-eligible populations. For Medicaid managed care stakeholders, this trend matters because D-SNP growth increases the complexity of Medicaid-Medicare coordination, integrated care requirements, and state contracting strategies for dually eligible enrollees.

milliman.com →
Milliman · Oct 22

State Medicaid Agencies Navigate Mental Health Parity Enforcement Amid Federal Uncertainty

This white paper examines how state Medicaid agencies can strengthen enforcement of mental health parity requirements for managed care entities, even as federal priorities shift following the 2025 suspension of certain commercial market rules. The analysis walks through the three types of treatment limitations under MHPAEA—financial requirements, quantitative limits, and nonquantitative treatment limitations—and emphasizes that existing Medicaid parity obligations remain in effect regardless of federal enforcement changes. For MCO compliance teams and state Medicaid directors, this offers a roadmap for improving oversight of behavioral health access in managed care programs, which collectively represent the largest payer for mental health and substance use disorder services.

milliman.com →
Milliman · Oct 22

State Medicaid Programs Face Operational Changes as 340B Shifts from Discount to Rebate Model in 2026

HRSA is launching a pilot program in January 2026 that fundamentally changes how the 340B drug pricing program works—moving from upfront discounts to a rebate model for 10 high-cost drugs subject to Medicare price negotiation. This shift has direct implications for state Medicaid programs and their managed care plans, particularly around duplicate discount prevention, claims processing, pharmacy reimbursement, and financial reconciliation processes that have been built around the traditional 340B discount structure for over 30 years. States need to assess operational readiness now to handle the accounting and reporting changes this model introduces.

milliman.com →
Milliman · Oct 13

Fluoridation Bans Could Raise Dental Claim Costs, Milliman Warns Insurers

Milliman analyzes how state-level bans on community water fluoridation (e.g., Florida, Utah) and potential federal policy shifts could increase future dental claims due to higher cavity rates, citing studies estimating billions in added costs nationally. While framed broadly for dental insurers, the analysis has relevance for Medicaid managed dental care plans that must anticipate utilization and cost trends tied to public health fluoridation policy changes.

milliman.com →

Get the daily briefing.